Skip to content

Author

Xiao-Long Liu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cascade Catalytic Nanozyme Amplifies Ferroptosis Immunotherapy in Bladder Cancer.

Immune checkpoint inhibitors have shown limited efficacy in bladder cancer due to the immunosuppressive tumor microenvironment. To address this challenge, we developed a β-lapachone-loaded iron-based carbon nanozyme (C-MIL@Lapa) that synergistically induces ferroptosis and immunogenic cell death (ICD). Carbonized MIL-1...

Hong-Bo Luo, Xiao-Long Liu, Yang Du · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.